Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
Park, J.C.; Krishnakumar, H.N.; Saladi, S.V. Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma. Curr. Oncol. 2022, 29, 4185-4198. https://doi.org/10.3390/curroncol29060334
Park JC, Krishnakumar HN, Saladi SV. Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma. Current Oncology. 2022; 29(6):4185-4198. https://doi.org/10.3390/curroncol29060334
Chicago/Turabian StylePark, Jong Chul, Hari N. Krishnakumar, and Srinivas Vinod Saladi. 2022. "Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma" Current Oncology 29, no. 6: 4185-4198. https://doi.org/10.3390/curroncol29060334